What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1).
2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670).
We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.
Entrada Therapeutics is engaging a consultant to provide interim, full-time support to the SEC Reporting & Technical Accounting function from approximately mid-November 2026 through early March 2027. This engagement backfills priority pre-year-end and year-end deliverables while the Associate Director, SEC Reporting temporarily takes on additional responsibilities elsewhere in the accounting organization.
The Associate Director will remain involved throughout the engagement and provide oversight/guidance as necessary.
ResponsibilitiesExternal Reporting:
- Lead the preparation of the Company’s Form 10-K
- Work closely with Controller, Associate Director SEC Reporting, COO and Legal to ensure all areas of our filings are complete and accurate
- Assist with the preparation of earnings releases and Form 8-Ks, as needed
- Prepare and/or review supporting schedules related to our external reporting
- Coordinate and manage annual audit by external auditors and relationships with supporting consultants
- Manage reporting timelines and communicate this clearly to relevant internal and external stakeholders
- Assist with Audit Committee agenda oversight and preparation of meeting materials
- Support preparation of the proxy statement as time allows
Technical Accounting:
- Manage the review of the Company annual tax provision and disclosures prepared by our external consultants
- Support technical accounting research as needed and document conclusions reached in a clear, logical, and comprehensive manner
- Collaborate with consultants for highly complex and judgmental technical accounting areas to ensure appropriate conclusions are reached
- Provide support to accounting team and monthly close processes related to key accounting topics and areas of judgment. Additionally, assist in preparing and/or reviewing certain accounting close areas as needed (e.g., revenue, leases, investments, etc.)
- Monitor development of emerging accounting pronouncements, determine the applicability to Entrada and support the implementation of new guidance, and communicate that to key stakeholders
- Manage the development/improvement and implementation of accounting policies and procedures for all our processes to ensure consistency in reporting
Controls and Compliance:
- Lead year-end SOX 404(a) compliance to support 10-K SOX conclusions
- Review SOC 1 reports for key vendors/service organizations
- Work with third party consultant to finalize SOX testing work
- Support Disclosure Committee agenda and related materials
- Determine financial statement materiality and related posting thresholds
- Other ad hoc projects with the Corporate Controller as needed
At Entrada, our passion for science, our devotion to patients and our values drives our behavior:
- Humanity - We genuinely care about patients and about one another.
- Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
- Creativity - We are creative problem solvers.
- Collaboration - We are more than the sum of our parts.
- Curiosity - We have a growth mindset and push conventional thought and theory.
To thrive on our team, you will need to come with:
- BA/BS degree with 7+ years of relevant experience or equivalent
- Prior experience with a top accounting firm and experience gained in a Life Science environment is preferred
- Experience working within a public company reporting structure is required
- Strong proficiency with Microsoft Office related products
- Experience with public company reporting required
- Strong technical accounting experience and research capabilities to properly determine accounting conclusions on key technical matters. Experience with collaboration revenue recognition (ASC606) is strongly preferred
- Knowledge of Accounting for Income Taxes (ASC 740) is strongly preferred
- Extensive knowledge of SOX 404(a) controls and requirements
- Experience with Workiva is a plus
- A can-do attitude and appetite for learning new things, including support for research on new accounting pronouncements
- You should be a strong communicator and have excellent organization skills
- We are a high growth, Company; you must possess strong change agility skills and an ability to continue to perform at a high level through change #LI-Remote #LI-GG1
Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.
Third Party Staffing AgenciesEntrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.
Privacy StatementEntrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.
Entrada Therapeutics Boston, Massachusetts, USA Office
6 Tide St, Boston, MA, United States, 02210
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
